Corneal Cross-linking


Cross-linking is the only approved treatment for CCLhalting the progression of keratoconus. Dr. Price, one of the most experienced surgeons at performing cross-linking in the United States, contributed to FDA approval of cross-linking and served as an investigator in the original USA clinical trials, starting back in 2008. As a result of these studies, the FDA determined that cross linking is a safe and effective treatment. The Price Vision Group team has also participated in some more recent clinical trials for advancements in cross-linking that are not yet approved.

The care I have received at Price Vision Group has been nothing short of exceptional. Embarking on this journey can be very scary and daunting task, but it something I recommend 100%.
– Justin Guerra (click here to see full testimonial)


The cross-linking procedure involves the combined use of riboflavin (vitamin B2) eye drops and UVA light to strengthen the front layers of the cornea. The company that received the FDA approval expects to have the riboflavin and UVA light commercially available by the end of 2016. Until then, Price Vision Group is providing patients access to cross-linking through an ongoing investigational study.

I have had cross-linking done in both eyes. The pain during the procedure was basically non-existent, and I just had an enjoyable hour-long conversation. I had a little pain the first night, but after that things were fine. Overall, it was very easy. They explain everything and tell you what to do. Just show up and you are good to go. My left eye has remained the same, which is good because it was 20/20 to start. My right eye which was worse has had some slight improvement since the procedure. Overall, I would say just do it, it’s easy.
– Eric Wenning (click here to see full testimonial)

Next Steps and Scheduling

For more information and to find out if you may be a candidate, please contact our office at (800) 317-3937 to schedule an appointment for an evaluation. You can also CLICK HERE for a brochure from the Cornea Research Foundation of America with CCL2more information about keratoconus and cross-linking. Please note that this brochure discusses the research study on cross-linking conducted jointly with the Price Vision Group, but the study has ended now that the procedure has been approved by the US Food and Drug Administration in April, 2016.  Despite the FDA approval, corneal cross-linking is currently still considered investigational and not covered by most medical insurance companies.

Back to Top

Contact Us

All fields required
By checking the box on the contact form, you agree to the Terms of Use listed here: Communications through our website or via email are not encrypted and are not necessarily secure. Use of the internet or email is for your convenience only, and by using them, you assume the risk of unauthorized use. By checking this box you hereby agree to hold Price Vision Group, its doctors and affiliates, harmless from any hacking or any other unauthorized use of your personal information by outside parties.

Indianapolis, IN
(800) 317-3937

Price Vision Group 9002 North Meridian Street #100
Indianapolis, IN 46260
Monday–Friday: 8 a.m.–5 p.m.
(317) 844-5530

Price Vision Group is a global leader in corneal transplant, cataract surgery, keratoconus treatment, PRK and LASIK. At our center in Indianapolis, we see patients from Indiana cities including Fishers, Carmel, Noblesville, Avon, and Greenwood, as well as people who travel from across the U.S. and even abroad for treatment by our renowned physicians.

Website Design & Marketing by Etna Interactive